Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...
Jim Ward's death confirmed at 66 after complications from Alzheimer's disease with tributes noting his roles on 'The Fairly ...
ADEL-Y01, a monoclonal antibody targeting tau protein, is in Phase I trials for Alzheimer's disease, developed by ADEL and ...
New research from the University of Virginia School of Medicine is revealing why traumatic brain injury increases the chance ...
Research published in the Journal of Alzheimer's Disease suggests findings could transform emergency protocols for the 2.5 ...
South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...
Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...
Fosun Pharma is spending 1.4 billion Chinese yuan ($200 million) to take on a 53% stake in Green Valley Pharmaceuticals and ...
A shared molecular signature of Alzheimer’s appears across populations once studied in isolation. Alzheimer's disease (AD) ...
University of Virginia School of Medicine researchers have uncovered how and why traumatic brain injury (TBI) increases the risk for Alzheimer's disease, and their work suggests a potential way to ...
New research shows that where a person lives can determine whether they receive timely diagnosis and care, or instead fall ...